Yes, Gene Therapy will be the next phase in the drug development world - however, most companies are overvalued and so are hard to invest in because of their risk/reward ratio.
They do have heaps of safety and manufacturing issues to overcome though.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $11.37M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $11.47K | 3.312M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 68 | 52690648 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 99819622 | 30 |
View Market Depth
| Last trade - 10.45am 07/08/2025 (20 minute delay) ? |
| CHM (ASX) Chart |